Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)
Condition: Hepatocellular Carcinoma Interventions: Drug: Regorafenib; Drug: Nivolumab Sponsors: Fundacion Clinic per a la Recerca Biomédica; Apices Soluciones S.L. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials